FDA Adverse Event Malfunction Summary report: N

SOLOGRIP III HANDPIECE

MDR report key: 2707338 · Received August 21, 2012

Report

Report Number
2950727-2012-00007
Event Type
Malfunction
Date Received
August 21, 2012
Date of Event
May 2, 2012
Report Date
August 21, 2012
Manufacturer
CARDIOGENESIS CORPORATION
Product Code
MNO
PMA / PMN Number
P970029
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT WAS PREVIOUSLY SUBMITTED AS MANUFACTURER REPORT NUMBER 1604318-2012-00020; HOWEVER, THE CORRECT MANUFACTURER REPORT NUMBER IS 2950727-2012-00007. A MANUFACTURING RECORDS REVIEW WAS PERFORMED TO DETERMINE IF THERE WERE ISSUES DURING MANUFACTURING THAT COULD BE ATTRIBUTED TO THE REPORTED EVENT. THERE WERE NO ISSUES DURING MANUFACTURING NOTED IN THE DEVICE HISTORY RECORD. UPON EVALUATION OF THE HANDPIECE, THE FIBERS WERE OBSERVED TO HAVE BEEN DAMAGED, POSSIBLY DUE TO SHARP BENDING OF THE FIBERS. CARDIOGENESIS CORPORATION IS IMPLEMENTING CHANGES TO ENSURE THERE ARE CLEAR PRECAUTIONS AGAINST BENDING THE FIBER OR THE WHITE TUBING AT A SHARP ANGLE OR OTHERWISE IMPEDING MOVEMENT OF THE FIBER.

Additional Manufacturer Narrative · 1

THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT.

Description of Event or Problem · 1

ACCORDING TO THE REPORT, FLAMES WERE EMITTED FROM THE PROXIMAL END OF THE SOLOGRIP III HANDPIECE AFTER APPROXIMATELY NINE CHANNELS WERE CREATED. NO INJURIES WERE REPORTED AND ANOTHER HANDPIECE WAS UTILIZED TO COMPLETE THE CASE.

Description of Event or Problem · 1

ACCORDING TO THE REPORT, FLAMES WERE EMITTED FROM THE PROXIMAL END OF THE SOLOGRIP III HANDPIECE AFTER CREATING APPROXIMATELY NINE CHANNELS. NO INJURIES WERE REPORTED AND ANOTHER HANDPIECE WAS UTILIZED TO COMPLETE THE CASE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SOLOGRIP III HANDPIECE TRANSMYOCARDIAL REVASCULARIZATION LASER HANDPIECE MNO CARDIOGENESIS CORPORATION 705-37020 TA-03733

Patients

Seq Age Sex Outcome Treatment
1